CJC-1295 no DAC + Ipamorelin

CJC-1295 and Ipamorelin are two complementary peptides commonly studied together for their ability to stimulate the body’s natural growth hormone (GH) release.

Rather than supplying exogenous growth hormone, this combination works by signaling the pituitary gland to increase endogenous GH secretion in a more physiologic, pulsatile pattern.

This synergistic pairing is widely researched for its effects on metabolism, recovery, sleep cycles, and cellular regeneration pathways.

CJC-1295 (Mod GRF 1-29)

A Growth Hormone–Releasing Hormone (GHRH) analog that stimulates the pituitary to release GH while extending the duration of GH pulses.

Ipamorelin

A selective growth hormone secretagogue that mimics ghrelin signaling, triggering GH release without significantly affecting cortisol or prolactin levels.

Synergistic Effect

When combined, CJC-1295 enhances the duration of GH pulses while Ipamorelin increases pulse amplitude, resulting in a stronger and more sustained endogenous GH release profile.